PSMA-PET guided dose-escalated volumetric arc therapy (VMAT) for newly diagnosed lymph node positive prostate cancer: Efficacy and toxicity outcomes at two years-Reference-Cited by-同舟云学术

PSMA-PET guided dose-escalated volumetric arc therapy (VMAT) for newly diagnosed lymph node positive prostate cancer: Efficacy and toxicity outcomes at two years

Published:2019-12 Issue: Volume:141 Page:188-191
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Shakespeare Thomas Philip,Eggert Elizabeth,Wood Maree,Westhuyzen Justin,Turnbull Kirsty,Rutherford Natalie,Aherne Noel

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference31 articles.

1. The STAMPEDE trial: paradigm-changing data through innovative trial design;Carthon;Transl Cancer Res,2016

2. National Comprehensive Cancer Network. Prostate Cancer (Version 4. 2018). Accessed 1 October 2018.

3. Radiotherapy for node-positive prostate cancer: 2019 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group;Lieng;Radiother Oncol,2019

4. Te Velde BL, Westhuyzen J, Awad N et al. Late toxicities of prostate cancer radiotherapy with and without hydrogel SpaceAOR insertion. J Med Imaging Radiat Oncol 2019 Sep 13. doi: 10.1111/1754-9485.12945. [Epub ahead of print].

5. Planning magnetic resonance imaging for prostate cancer intensity-modulated radiation therapy: Impact on target volumes, radiotherapy dose and androgen deprivation administration;Horsley;Asia Pac J Clin Oncol,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) of prostate cancer: current and emerging applications;Abdominal Radiology;2024-02-22

2. Prostate‐specific membrane antigen positron emission tomography detected local failure after post‐prostatectomy radiation therapy: Low rates of out‐of‐field recurrence validates current Australian prostate bed contouring guidelines;Journal of Medical Imaging and Radiation Oncology;2023-07-03

3. PSMA‐PET‐guided dose‐escalated volumetric arc therapy for newly diagnosed lymph node‐positive prostate cancer: 5 Year outcomes following the FROGG and EviQ node‐positive guidelines;Journal of Medical Imaging and Radiation Oncology;2023-04-26

4. PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature;Cancers;2022-03-31

5. Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting;La radiologia medica;2021-11-30